FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041566384> ?p ?o ?g. }

• W2041566384 endingPage "213" @default.
• W2041566384 startingPage "203" @default.
• W2041566384 abstract "Fasting plasma mevalonic acid (MVA), an indicator of in vivo cholesterol synthesis, was measured in 35 patients with familial hypercholesterolaemia (FH) of whom 7 were treated with pravastatin 10-40 mg/day, 7 with simvastatin 10-40 mg/day and 21 with atorvastatin 80 mg/day. Reductions in low density lipoprotein (LDL) cholesterol and MVA on maximal dose therapy differed significantly between the three drugs: 34.7%, 42.9% and 54.0% (P = 0.0001), and 31.6%, 48.9% and 58.8% (P = 0.004), respectively. Patients on atorvastatin were subdivided according to whether their reduction in LDL cholesterol on treatment was above or below the mean percentage change for the whole group. Basal values of LDL cholesterol did not differ significantly, but above average responders had a significantly higher mean pre-treatment level of MVA (6.2 +/- 0.60 vs. 4.3 +/- 0.61 ng/ml, P < 0.05) than below average responders. When all three drug groups were pooled above average responders showed a significantly greater absolute decrease in MVA on treatment than below average responders (3.85 +/- 0.48 vs. 2.33 +/- 0.40 ng/ml, P < 0.05). However, there was no significant correlation between the magnitude of the decreases in LDL cholesterol and MVA. These findings suggest that FH patients who responded well to statins had a higher basal level of plasma MVA, i.e. a higher rate of cholesterol synthesis, which was more susceptible to pharmacological inhibition. The more marked cholesterol lowering effect of atorvastatin 80 mg/day presumably reflects, at least in part, its ability to inhibit HMG-CoA reductase to a greater extent than maximal recommended doses of pravastatin and simvastatin of 40 mg/day." @default.
• W2041566384 created "2016-06-24" @default.
• W2041566384 creator A5015667427 @default.
• W2041566384 creator A5016481723 @default.
• W2041566384 creator A5034466911 @default.
• W2041566384 creator A5035047137 @default.
• W2041566384 creator A5039396185 @default.
• W2041566384 creator A5054820107 @default.
• W2041566384 creator A5069939170 @default.
• W2041566384 date "1996-01-01" @default.
• W2041566384 modified "2023-10-04" @default.
• W2041566384 title "Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia" @default.
• W2041566384 cites W1555373432 @default.
• W2041566384 cites W1844308307 @default.
• W2041566384 cites W1965301360 @default.
• W2041566384 cites W1974517335 @default.
• W2041566384 cites W1975724858 @default.
• W2041566384 cites W1989046290 @default.
• W2041566384 cites W1995069196 @default.
• W2041566384 cites W1997092401 @default.
• W2041566384 cites W2001723893 @default.
• W2041566384 cites W2005169645 @default.
• W2041566384 cites W2022626418 @default.
• W2041566384 cites W2024716729 @default.
• W2041566384 cites W2027057348 @default.
• W2041566384 cites W2042743213 @default.
• W2041566384 cites W2068765374 @default.
• W2041566384 cites W2071124826 @default.
• W2041566384 cites W2074444487 @default.
• W2041566384 cites W2084462402 @default.
• W2041566384 cites W2088205396 @default.
• W2041566384 cites W2094314233 @default.
• W2041566384 cites W2100558183 @default.
• W2041566384 cites W2100680747 @default.
• W2041566384 cites W2106536809 @default.
• W2041566384 cites W2116404316 @default.
• W2041566384 cites W2123179341 @default.
• W2041566384 cites W2125437523 @default.
• W2041566384 cites W2125967584 @default.
• W2041566384 cites W2133945578 @default.
• W2041566384 cites W2135860409 @default.
• W2041566384 cites W2146875849 @default.
• W2041566384 cites W2147901270 @default.
• W2041566384 cites W2148463229 @default.
• W2041566384 cites W2152103617 @default.
• W2041566384 cites W2335950035 @default.
• W2041566384 cites W2419148542 @default.
• W2041566384 doi "https://doi.org/10.1016/0021-9150(95)05649-1" @default.
• W2041566384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8808497" @default.
• W2041566384 hasPublicationYear "1996" @default.
• W2041566384 type Work @default.
• W2041566384 sameAs 2041566384 @default.
• W2041566384 citedByCount "83" @default.
• W2041566384 countsByYear W20415663842012 @default.
• W2041566384 countsByYear W20415663842013 @default.
• W2041566384 countsByYear W20415663842014 @default.
• W2041566384 countsByYear W20415663842015 @default.
• W2041566384 countsByYear W20415663842016 @default.
• W2041566384 countsByYear W20415663842017 @default.
• W2041566384 countsByYear W20415663842019 @default.
• W2041566384 crossrefType "journal-article" @default.
• W2041566384 hasAuthorship W2041566384A5015667427 @default.
• W2041566384 hasAuthorship W2041566384A5016481723 @default.
• W2041566384 hasAuthorship W2041566384A5034466911 @default.
• W2041566384 hasAuthorship W2041566384A5035047137 @default.
• W2041566384 hasAuthorship W2041566384A5039396185 @default.
• W2041566384 hasAuthorship W2041566384A5054820107 @default.
• W2041566384 hasAuthorship W2041566384A5069939170 @default.
• W2041566384 hasConcept C104950815 @default.
• W2041566384 hasConcept C126322002 @default.
• W2041566384 hasConcept C134018914 @default.
• W2041566384 hasConcept C134651460 @default.
• W2041566384 hasConcept C150903083 @default.
• W2041566384 hasConcept C181199279 @default.
• W2041566384 hasConcept C185592680 @default.
• W2041566384 hasConcept C207001950 @default.
• W2041566384 hasConcept C2776329913 @default.
• W2041566384 hasConcept C2777320049 @default.
• W2041566384 hasConcept C2777482532 @default.
• W2041566384 hasConcept C2778024521 @default.
• W2041566384 hasConcept C2778163477 @default.
• W2041566384 hasConcept C2779120738 @default.
• W2041566384 hasConcept C2779306644 @default.
• W2041566384 hasConcept C2779519902 @default.
• W2041566384 hasConcept C2780361610 @default.
• W2041566384 hasConcept C3017755632 @default.
• W2041566384 hasConcept C55493867 @default.
• W2041566384 hasConcept C71924100 @default.
• W2041566384 hasConcept C86803240 @default.
• W2041566384 hasConceptScore W2041566384C104950815 @default.
• W2041566384 hasConceptScore W2041566384C126322002 @default.
• W2041566384 hasConceptScore W2041566384C134018914 @default.
• W2041566384 hasConceptScore W2041566384C134651460 @default.
• W2041566384 hasConceptScore W2041566384C150903083 @default.
• W2041566384 hasConceptScore W2041566384C181199279 @default.
• W2041566384 hasConceptScore W2041566384C185592680 @default.
• W2041566384 hasConceptScore W2041566384C207001950 @default.
• W2041566384 hasConceptScore W2041566384C2776329913 @default.

• next